Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan  by Huang, L.-Y. et al.
ORIGINAL ARTICLE 10.1111/j.1469-0691.2008.02077.x
Dissemination of multidrug-resistant, class 1 integron-carrying
Acinetobacter baumannii isolates in Taiwan
L.-Y.Huang1, T.-L.Chen2,3, P.-L. Lu4, C.-A. Tsai5,W.-L. Cho3, F.-Y. Chang6, C.-P. Fung2,3 and L. K. Siu6,7
1Graduate Institute of Medical Sciences, 2Section of Infectious Diseases, Department of Medicine,
Taipei Veterans General Hospital, 3Institute of Clinical Medicine, School of Medicine, National Yang-
Ming University, Taipei, 4Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung
Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 5Section of Infectious
Diseases, Department of Medicine, Taichung Veterans General Hospital, Taichung, 6Department of
Medicine, Tri-Service General Hospital, National Defence Medical Centre and 7Division of Clinical
Research, National Health Research Institutes, Taiwan
ABSTRACT
In this study, 283 multidrug-resistant Acinetobacter baumannii (MDR-AB) bloodstream isolates were
collected between 1996 and 2004, from three teaching hospitals located in different regions of Taiwan.
Susceptibility data showed that strains carrying class 1 integrons were signiﬁcantly more resistant
(p <0.01) to all tested antibiotics (except aztreonam and chloramphenicol) than strains lacking integrons,
Seven types of gene cassette were identiﬁed among these strains, including two that have not been
previously reported. The vast majority of the cassettes encoded aminoglycoside resistance genes,
including aacA4, aacC1, aac(6¢)-II, aadA1, aadA2, aadA4 and aadDA1. Sixteen distinct ribotypes were
identiﬁed in MDR-AB isolates carrying class 1 integrons. Only one strain was found to produce an
extended-spectrum b-lactamase, i.e. VEB-3. In the 18 imipenem-resistant strains, two carbapenenmase
genes, blaVIM-11 and blaOXA-58, were found concomitantly in one isolate. An island-wide epidemic clone
and an endemic clone from a hospital located in the northern region were identiﬁed by ribotyping. On
the basis of the susceptibility data among the different ribogroups, the epidemic clone was associated
more signiﬁcantly with resistance to cefepime and ampicillin–sulbactam than was the endemic clone. In
conclusion, the presence of class 1 integrons was signiﬁcantly associated with resistance in MDR-AB,
and the epidemic, class 1 integron-carrying MDR-AB clone was found to be widespread in Taiwan.
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INTRODUCTION
Acinetobacter baumannii is an important cause of
nosocomial infections, especially in intensive-care
units, and has been documented to be the major
cause of ventilator-associated pneumonia and
bacteraemia [1,2]. Its rapid acquisition of a wide
variety of antibiotic resistance genes, as well as its
ability to survive in various harsh environments,
has caused difﬁculties in the control and eradica-
tion of the pathogen [3]. This extremely rapid
development of resistance has caused serious
therapeutic problems worldwide [4,5].
Mobile elements, including plasmids, transpo-
sons and integrons, are the most efﬁcient genetic
elements promoting acquisition anddissemination
of resistance determinants. Integrons carrying
diverse arrays of resistance gene cassettes [6,7]
are particularly useful for the epidemiological
study of A. baumannii [8]. Currently, ﬁve distinct
classes of integrons have been described [6].
Class 1 integrons are commonly found in clinical
isolates of Gram-negative bacilli, including
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A. baumannii [8,9]. In Taiwan, integron-associated
multidrug resistance in A. baumannii has been
investigated only in a single hospital [10,11].
However, no large-scale study has been carried
out concerning the role of integrons in multidrug-
resistant A. baumannii (MDR-AB) isolates in Tai-
wan. In this study, a comparison of integron-
carrying and non-integron-carrying MDR-AB
strains was made to assess the differences in their
drug susceptibility and clonal dissemination.
MATERIALS AND METHODS
Isolates
Between July 1996 and December 2004, a total of 283 non-
repetitive clinical blood isolates of MDR-AB were collected
from three medical centres located in different regions of
Taiwan. Among these, 195 isolates were obtained from
the northern region (Taipei Veterans General Hospital),
50 from the central region (Taichung Veterans General
Hospital) and 38 from the southern region (Kaohsiung
Medical University Hospital). A. baumannii isolates resistant
to three or more different classes of antibiotics, including at
least one extended-spectrum b-lactam antibiotic, were
deﬁned as MDR-AB [12]. All clinical isolates were identiﬁed
using the API 32GN system (bioMerieux, Marcy-l’Etoile,
France). Species identiﬁcation was further conﬁrmed using
a multiplex PCR based on the intergenic spacer region of
the 16S–23S rRNA genes [13]. An endemic strain (R-25)
identiﬁed in a previous study [11] was used for compari-
son with the isolates of this study. Bacteria were stored at
)70C using a Microbank system (Prolab Diagnostics,
Neston, UK).
Integron detection and typing
Detection of the class 1 integrase gene (integrase gene PCR)
and integron cassettes (integron PCR) were performed as
described previously [9]. Class 2 and class 3 integrons were
detected using PCR as described by Poly et al. [14]. A long-
range PCR assay for integron cassettes was performed with
Blend Taq Plus DNA polymerase (Toyobo, Osaka, Japan)
with the representatives of each PCR–restriction fragment
length polymorphism pattern to conﬁrm the presence of
large integrons. Integron PCR products were puriﬁed using
Microspin S-300 HR columns (GE Healthcare, Uppsala,
Sweden). The typing of the integron gene cassettes was
done by restriction analysis using AluI (New England
Biolabs, Beverly, MA, USA). The fragments, after restriction
digestion, were resolved with 2% agarose gel electrophoresis
in TBE buffer at 100 V and examined after ethidium
bromide staining. Integron PCR products with different
PCR–restriction fragment length polymorphism patterns
were selected, puriﬁed and subcloned using a TOPO TA
cloning kit (Invitrogen, Carlsbad, CA, USA) for sequencing.
Additional primers were designed on the basis of sequences
obtained to complete the entire sequence of the gene
cassettes. Sequence analysis and comparison were carried
out using the BLAST program supported by the NCBI
database (http://www.ncbi.nlm.nih.gov).
Antimicrobial susceptibility testing
The antimicrobial agents used in this study include chloram-
phenicol, ampicillin–sulbactam (2 : 1; w ⁄w), piperacillin, piper-
acillin with a ﬁxed concentration of tazobactam at 4 mg ⁄L,
aztreonam, ceftazidime, ceftriaxone, cefepime, imipenem, gen-
tamicin, tobramycin, amikacin and ciproﬂoxacin. All drugs
were incorporated intoMueller–Hintonbroth (TREKDiagnostic
Systems Ltd, East Grinstead, UK). The concentration of drugs
usedwas from0.03 to 128 mg ⁄L,with two-fold increments. Two
control strains, Escherichia coli ATCC 25922 and Pseudomonas
aeruginosaATCC 27853, were included to determine theMIC of
the drugs. Antimicrobial susceptibility was determined by
automated SensiTitre Susceptibility Plate (Trek Diagnostic
Systems Ltd) according to the CLSI recommendations [15].
b-Lactamase detection
Extended-spectrum b-lactamase (ESBL) production screening
was performed using the double-disk synergy test with cefe-
pime, ceftazidime and ticarcillin–clavulanic acid on Mueller–
Hinton agar and also on plates containing cloxacillin
(200 lg ⁄mL) to inhibit the naturally occurring AmpC-type
b-lactamases in A. baumannii [16]. PCR testing of synergy-
positive isolates for known ESBL genes was done using speciﬁc
primers for blaTEM, blaSHV, blaCTX-M, blaVEB and blaPER [17,18].
The amplicons obtainedwere identiﬁed by sequencing. Primers
VEB-FcandVEB-Rc [19]wereused for ampliﬁcationof the entire
blaVEB gene. In imipenem-resistantMDR-ABstrains, thegenesof
the carbapenem-hydrolysing oxacillinasesOXA-23 andOXA-58
were also detected by PCR as previously described [20].
Molecular typing
Ribotyping was used to determine the epidemiological rela-
tionship among A. baumannii isolates harbouring class 1
integrons. Ribotyping was performed using the automated
Riboprinter Microbial Characterization System (Qualicon,
Wilmington, DE, USA) according to the manufacturer’s
instructions and the protocols described by Wu et al. [11]. To
reveal ribotype polymorphism, each sample was analysed by
the Molecular Analyst Fingerprinting, Fingerprinting Plus and
Fingerprinting DST Software (Bio-Rad Laboratories, Rich-
mond, CA, USA). The grouping method was used to generate
a dendrogram from the matrix using the unweighted pair
group method using arithmetic average (UPGMA) clustering
technique after calculation of similarities using Pearson corre-
lation coefﬁcients between every pair of organisms.
Pulsed-ﬁeld gel electrophoresis (PFGE) was used for further
subtyping of the isolates of each major ribopattern. Total DNA
was prepared and PFGE was performed as described previ-
ously [21]. ApaI (New England Biolabs, Beverly, MA, USA)
was used, and restriction fragments were separated by PFGE
in 1% SeaKem Gold agarose gels (Cambrex Bio Science,
Rockland, ME, USA) in 0.5 · TBE buffer (45 mM Tris, 45 mM
boric acid, 1.0 mM EDTA, pH 8.0) using a Bio-Rad CHEF-
Mapper apparatus (Bio-Rad Laboratories). Gels were stained
with ethidium bromide and photographed under ultraviolet
light. Band patterns were compared and classiﬁed as indistin-
guishable (clonal), closely related (clonal variants, with £3
band differences), possibly related (four to six band differ-
ences) or unrelated, using previously described criteria [22].
Dendrograms showing percentage similarity were prepared
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with the Molecular Analyst Fingerprinting, Fingerprinting
Plus and Fingerprinting DST Software (Bio-Rad Laboratories)
and compared using the UPGMA clustering method.
Statistical analysis
The susceptibility differences among MDR-AB stains were
analysed using the EPI INFO 6 programme (CDC, USA),
available at (http://www.cdc.gov/epiinfo/Epi6/ei6.htm). The
chi-square test was used to determine the signiﬁcance of
differences. Yate’s correction was used when any parameter to
be compared had a frequency of less than ﬁve. A difference
was considered statistically signiﬁcant if the p value was less
than 0.05. Fisher’s exact test was performed when the sample
number was less than ﬁve.
Nucleotide accession numbers
The sequences of the variable regions of the integrons of
representative strains K43 (type 2 cassette) and K46 (type 7
cassette) were deposited in GenBank under the accession
numbers EF127959 and EF116550, respectively.
RESULTS
Antimicrobial susceptibility testing
Among the 283 isolates analysed by PCR, 202
isolates were found to have the class 1 integrase
gene (intI1+), whereas the rest did not (intI1)).
Among the intI1+ isolates, 120 (59.4%) were found
in northern Taiwan, 49 (24.3%) in the central
region, and 33 (16.3%) in the southern region.
MDR-AB isolates with intI1 were resistant to
almost all of the tested antibiotics, with the
exception of imipenem, and were signiﬁcantly
more resistant to all of the antibiotics tested
(except aztreonam and chloramphenicol) than
intI1) MDR-AB isolates (p <0.001) (Table 1).
Detection and typing of class 1 integrons
Among the 202 (71.38%) class 1 integron-carrying
isolates, ﬁve different types of gene cassettes in
segments of approximately 2.5, 2.0, 1.4, 1.2 and
1.0 kb, between the 5¢-conserved segment (CS)
and 3¢-CS regions, were ampliﬁed by PCR.
To further differentiate among these ﬁve gene
cassette amplicons, all were subjected to AluI
restriction analysis, and their product sizes were
compared. Three additional subtypes were iden-
tiﬁed in the 2.5-kb cassette sequences, resulting in
a total of seven cassette types. Isolates carrying
one of these seven types were randomly selected
for sequencing. Sequencing results for each of the
seven amplicons revealed that these cassette
arrays carried various open reading frames
(ORFs) (Fig. 1). The ORFs of the three subtypes
in the c. 2.5-kb sequences included: type 1, aacC1-
orfX-orfX¢-aadDA1; type 2, blaIMP-8-aac(6¢)-II-
addA4; and type 3, aacA4-cat8-aadA1. These were
2542, 2507 and 2381 bp long, respectively. When
the c. 2.0-kb, 1.4-kb, 1.2-kb and 1.0-kb cassette
sequences were determined, the ORFs identiﬁed
included: type 4, dhfrXII-orfF-aadA2 (1873 bp);
type 5, arr-3-accA4 (1395 bp); type 6, dfrA1-orfC
(1242 bp); and type 7, blaVIM-11 (1062 bp)
(Table 2). The cassettes of type 3 accounted for
71.7% of all cassettes, making it the most common
type in the integron-carrying MDR-AB isolates.
Four cassette types (types 1, 2, 5 and 7) were
identiﬁed among the strains isolated from the
hospital located in the southern region, and the
others, i.e. cassette types 3, 4 and 6, were found in
isolates from at least two regions of Taiwan. Two
Table 1. Susceptibility testing results of intI1+ and intI1) Acinetobacter baumannii isolates from three medical centres in
northern, central and southern Taiwan
Antibiotic
intI1+ Isolates (n = 202), MIC (mg ⁄L) intI1) Isolates (n = 81), MIC (mg ⁄L)
p valueaRange MIC50 MIC90 Resistance (%) MIC50 MIC90 Resistance (%)
PIP £4 to ‡128 ‡128 ‡128 198 (98.0) ‡128 ‡128 61 (75.3) <0.001
PIP ⁄TAZ £2 to ‡128 ‡128 ‡128 187 (92.6) 64 ‡128 41 (50.6) <0.001
AZTb £1 to ‡32 ‡32 ‡32 198 (98.0) ‡32 ‡32 77 (95.1) 0.336
CRO £2 to ‡64 ‡64 ‡64 199 (98.5) ‡64 ‡64 70 (86.4) <0.001
CAZ £1 to ‡64 ‡64 ‡64 196 (97.0) 32 ‡64 47 (58.0) <0.001
FEP £0.5 to ‡32 ‡32 ‡32 169 (83.7) 16 ‡32 37 (45.7) <0.001
IMP £0.25 to ‡64 2 4 17 (8.4) 0.5 1 1 (1.2) 0.049
AMP ⁄ SUL £0.5 to ‡32 ‡32 ‡32 155 (76.7) 16 ‡32 28 (34.6) <0.001
GEN £0.25 to ‡16 ‡16 ‡16 192 (95.0) ‡16 ‡16 49 (60.5) <0.001
AMK £1 to ‡64 ‡64 ‡64 190 (94.1) 16 ‡64 33 (40.7) <0.001
TOB £0.5 to ‡16 ‡16 ‡16 189 (95.6) ‡16 ‡16 43 (53.1) <0.001
CHLb £2 to ‡32 ‡32 ‡32 202 (100) ‡32 ‡32 80 (98.8) 0.063
CIP £0.03 to ‡4 ‡4 ‡4 175 (86.6) 2 ‡4 36 (44.4) <0.001
PIP, piperacillin; PIP ⁄TAZ, piperacillin with a ﬁxed concentration of tazobactam at 4 mg ⁄L; AZT, aztreonam; CRO, ceftriaxone; CAZ, ceftazidime; FEP, cefepime; IMP,
imipenem; AMP ⁄ SUL, amplicillin–sulbactam at a 2 : 1 ratio; GEN, gentamicin; AMK, amikacin; TOB, tobramycin; CHL, chloramphenicol; CIP, ciproﬂoxacin.
aA p-value of <0.05 is considered to indicate a signiﬁcant difference in resistance between intI1+ and intI1– isolates.
bThe drug was not listed in the CLSI informational supplement [47] for the Acinetobacter species after 2006.
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novel integron cassette arrays were identiﬁed,
which comprised the metallo-b-lactamase (MBL)
genes blaIMP-8 and blaVIM-11, and also encoded
resistance to aminoglycosides, chloramphenicol,
folate pathway inhibitors, carbapenems and ans-
amycins. The vast majority of cassettes encoded
various aminoglycoside resistance genes (Table 2).
Neither a class 2 nor a class 3 integron was
detected in the other isolates. With regard to the
imipenem susceptibility of the MBL gene cassette-
carrying MDR-AB isolates, three isolates with a
blaIMP-8 cassette showed varying susceptibilities
(MICs: 4, 8 or 32 mg ⁄L) and two isolates with a
blaVIM-11 cassette showed high-level imipenem
resistance (MIC: 32 mg ⁄L).
b-Lactamase detection
With the exception of the C2 strain (ribotype
(R)15) (Fig. S1), all strains yielded negative results
for ESBL production using either Mueller–Hinton
agar or cloxacillin plates. PCR with primers for
known ESBL genes in the C2 strain was positive
for blaVEB. DNA sequencing of the full-length
blaVEB gene revealed the blaVEB-3 variant. Among
18 imipenem-resistant strains (Table 3), OXA-23
Fig. 1. Schematic representation of
the variable regions identiﬁed in
multidrug-resistant Acinetobacter
baumannii (MDR-AB) isolates. Cas-
sette types (1–7) are arranged as
identiﬁed in Table 2. Gene cassettes
are shown as boxes, with arrows
indicating the orientation of tran-
scription and black circles indicating
the 59-base elements. Hatched rect-
angles indicate 5¢- and 3¢-conserved
segments (CSs). The 5¢-CS and 3¢-CS
ampliﬁcation primers are indicated
by arrowheads.
Table 2. Relationships among cassette types, amplicon size of conserved regions, gene arrays, resistance patterns and
associated ribotypes
Cassette type
(no. of isolates)
Amplicon
size (bp) Resistance gene(s) Resistance phenotype Accession no. Ribotype (no. of isolates)
1 (4) 2542 aacC1, orfX, orfX¢, aadDA1 Gen, Sis, Ast, Spt, Str AY307113 R7(3), R3
2 (3) 2507 blaIMP-8, aac(6¢)-II, aadA4 Imp, Tob, Net, Gen, Spt, Str EF127959a R4, R15, R16
3 (145) 2381 aacA4, catB8, aadA1 Amk, Net, Tob, Chl, Spt, Str AY922989 R5(130), R6(5), R7(4), R9(3), R2, R8, R15
4 (34) 1873 dhfrXII, orfF, aadA2 Tmp, Spt, Str DQ995286 R6(32), R9, R15
5 (1) 1395 arr-3, aacA4 Rif, Amk, Net, Tob AY038837 R10
6 (13) 1242 dfrA1, orfC Tmp DQ123842 R15(5), R14(2), R1,
R5, R6, R9, R11, R13
7 (2) 1062 blaVIM-11 Imp EF116550
a R12(2)
Gen, gentamicin; Sis, sisomicin; Ast, astromicin; Spt, spectinomycin; Str, streptomycin; Imp, imipenem; Tob, tobramycin; Net, netilmicin; Amk, amikacin; Chl, chlorampenicol;
Tmp, trimethoprim; Rif, rifampin.
aIn this study.
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and OXA-58 carbapenemase genes were also
detected by PCR. Six strains contained blaOXA-58,
but blaOXA-23 was not detected. Two carbapenem-
ase genes, blaVIM-11 and blaOXA-58, were found
concomitantly in one isolate.
Genotyping of integron-carrying MDR-AB
isolates
Sixteen distinct ribotypes were identiﬁed among
202 class 1 integron-associated MDR-AB isolates.
The predominant clone in all three regions
(represented by 131 (64.8%) of the 202 isolates)
belonged to R5. The R5 clone members were
identical to the control strain R-25 described by
Wu et al. [11], representing a major clone in
another hospital in Taiwan. Approximately 20%
of the R5 isolates were randomly selected from
three hospitals for further subtyping by PFGE
(Fig. 2). PFGE proﬁles of randomly selected R5
strains revealed that the isolates were clonally
related. Apart from the R5 isolates, the R6
isolates were found to be high in prevalence in
the northern region and rarely found in other
regions. Only one isolate from the central region
and three isolates from the southern region
were observed to be of the R6 type. Further
subtyping of the R6 strains by PFGE showed
clonal spread of R6 only among the isolates
from the northern hospital, indicating endemic
spread in that hospital (Fig. 2). Taken together,
R5 isolates belonged to an island-wide epidemic
clone, whereas R6 isolates belonged to a hospi-
tal-endemic clone found in the northern region.
Two ribotypes, R9 and R15, were also found in
(at least) two hospitals. PFGE showed that R9
and R15 were non-clonal (data not shown). A
limited diversity of gene cassette arrays was
revealed in 16 ribotypes (Table 2). All 131 R5
isolates carried the type 3 cassette arrangement,
and all except one carried the type 6 cassette.
Relationship between molecular types and
antimicrobial susceptibility patterns
In order to investigate the relationship between the
antibiotic susceptibility differences among intI+
MDR-AB isolates, the molecular types were
divided into three groups: group 1 (R5), island-wide
epidemic clone; group 2 (R6), hospital endemic
clone in the northern region; and group 3 (ribo-
types other than R5 and R6), sporadic isolates. On
comparison of group 1 strains to group 2 strains,
group 1 strainswere signiﬁcantlymore resistant to
cefepime and ampicillin–sulbactam. Further com-
parison of the three groups of isolates showed that
both group 1 and group 2 isolates were signiﬁ-
cantly more resistant than group 3 isolates to all
b-lactam–b-lactamase inhibitor combinations
(piperacillin–tazobactam and ampicillin–sulbac-
tam), aminoglycosides (gentamicin, amikacin and
Table 3. Characteristics of imipenem-resistant multidrug-resistant Acinetobacter baumannii blood isolates examined in the
present study
Isolate Date of isolation
MIC (mg ⁄L)
Ribotype
Resistance determinant identiﬁed
IMP CAZ PIP ⁄TAZ AZT FEP intI1 MBL cassette CHDL ESBL
1 15 May 1998 32 ‡64 ‡128 ‡32 ‡32 R14 + ) ) )
2 16 September 2001 ‡64 8 64 ‡32 8 ND ) ) ) )
3 12 January 2004 16 ‡64 ‡128 ‡32 ‡32 R9 + ) + (OXA-58) )
4 18 February 2004 16 ‡64 ‡128 ‡32 ‡32 R15 + ) + (OXA-58) )
5 14 July 2004 16 ‡64 ‡128 ‡32 ‡32 R5 + ) ) )
6 2 August 2004 ‡64 ‡64 ‡128 ‡32 ‡32 R5 + ) + (OXA-58) )
7 18 August 2004 16 ‡64 ‡128 ‡32 ‡32 R15 + ) ) )
8 27 August 2004 ‡64 ‡64 ‡128 ‡32 ‡32 R5 + ) ) )
9 3 September 2004 16 ‡64 ‡128 ‡32 ‡32 R5 + ) ) )
10 3 October 2004 32 ‡64 ‡128 ‡32 ‡32 R16 + + (IMP-8) ) )
11 12 October 2004 32 ‡64 ‡128 ‡32 ‡32 R13 + ) ) )
12 13 October 2004 32 ‡64 £2 8 16 R12 + + (VIM-11) ) )
13 17 October 2004 32 ‡64 ‡128 ‡32 ‡32 R15 + ) ) )
14 1 December 2004 32 ‡64 ‡128 ‡32 ‡32 R6 + ) + (OXA-58) )
15 1 December 2004 16 ‡64 64 ‡32 ‡32 R15 + ) ) )
16 5 December 2004 16 ‡64 ‡128 ‡32 ‡32 R5 + ) ) )
17 7 December 2004 32 ‡64 64 ‡32 ‡32 R12 + + (VIM-11) + (OXA-58) )
18 17 December 2004 32 ‡64 ‡128 ‡32 ‡32 R15 + ) + (OXA-58) )
IMP, imipenem; CAZ, ceftazidime; PIP ⁄TAZ, piperacillin with a ﬁxed concentration of tazobactam at 4 mg ⁄L; AZT, aztreonam; FEP, cefepime; intI1, class 1 integrase gene;
MBL cassette, metallo-b-lactamase gene-carrying cassette; CHDL, carbapenem-hydrolysing class D b-lactamase; ESBL, extended-spectrum b-lactamase; ND, not determined.
ND, not done.
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(a)
(b)
Fig. 2. (a) Pulsed-ﬁeld gel electrophoresis (PFGE) analysis by ApaI restriction enzyme digestion of 43 Acinetobacter
baumannii isolates with ribotype (R)5 (left panel) and R6 (right panel). Isolates from different geographical areas are shown
as follows: lane 1, R25 control endemic clone from another hospital in Taiwan [11]; lanes 2–15, northern Taiwan R5 isolates;
lanes 16–23, central Taiwan R5 isolates; lanes 24–28, southern Taiwan R5 isolates; lanes 29–39, northern Taiwan R6 isolates;
lane 40, central Taiwan R6 isolate; lanes 41–43, southern Taiwan R6 isolates; lane M, molecular weight marker. (b)
Dendrogram generated by UPGMA clustering. Isolates with similarity of >90% were considered to be identical; isolates
with <70% similarity (>3 band difference) were considered to be non-clonally related. Tol, tolerance; OPT, optimum; Min,
minimum; UPGMA, unweighted pair group method using arithmetic averages.
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tobramycin) and ciproﬂoxacin (Table 4). All R5
strains except one contained the type 3 cassettes,
but their antimicrobial susceptibility proﬁles var-
ied. Although the presence of aacA4 in R5 strains
was expected to correlate well with aminoglyco-
side resistance, six R5 isolates showed susceptibil-
ity to amikacin or tobramycin, despite carrying
aacA4.
DISCUSSION
This study showed that MDR-AB isolates carry-
ing integrons were signiﬁcantly more resistant to
all antibiotics tested (except aztreonam and
chloramphenicol) than non-integron-carrying iso-
lates. Integrons comprise one type of the gene
acquisition elements that drive horizontal gene
exchange [6,7]. It could be postulated that integ-
rons confer a selective advantage to strains in
environments under intense antibiotic pressure
[8]. Integron-carrying MDR-AB isolates have been
observed in geographical regions other than
Taiwan, including China (52.8%, 56 ⁄ 106) [23]
and Spain (84%, 59 ⁄ 70) [24]. R15 MDR-AB strains
carrying different gene cassettes (integron cassette
types 2, 3, 4, and 6) were found to have similar
multidrug resistance proﬁles, demonstrating the
association of integrons and multidrug resistance
(Table S1).
Among all integron carriers, seven integron
cassette types were identiﬁed on the basis of their
restriction fragment proﬁles (Fig. 1; Table 2).
Type 1, 3, 4 and 6 cassettes have been previously
documented in A. baumannii worldwide
[8,23,25,26]. The type 3 cassette was the most
prevalent (71.7%) in this study, as well as in a
report from China (55.5%, 30 ⁄ 54) [23]. The type 4
cassette has appeared in Gram-positive clinical
isolates of Staphylococcus aureus and Enterococcus
faecalis in China [27]. The type 6 cassette has
recently been identiﬁed in an epidemic MDR-AB
strain, AYE, in France [28], within a 86-kb island
of multidrug resistance genes [29]. The type 5
cassette has been reported only in Acinetobacter
strains in Hong Kong [30]. Two novel MBL
cassettes, of types 2 and 7, which carry the IMP-
8 and VIM-11 genes, have been identiﬁed only in
Klebsiella pneumoniae [31] and A. haemolyticus
(GenBank accession number DQ022682) in Tai-
wan. Taken together, the presence of integron
cassettes may indicate horizontal antibiotic
resistance gene transfer as well as the dissemina-
tion of carbapenem resistance.
Although gene cassettes encoding resistance to
a wide range of antibiotics have been reported in
A. baumannii, aminoglycoside resistance determi-
nants, including aacA4, aacC1, aac(6¢)-II, aadA1,
aadA2, aadA4 and aadDA1, were predominantly
found in this study. The high prevalence of
aminoglycoside resistance genes in the A. bau-
mannii integrons described here was comparable
to that observed in other studies [8,23,32,33].
Several MDR-AB isolates (6 ⁄ 132; 4.55%) harbour-
ing aacA4 did not confer resistance to amikacin
and tobramycin. Similar ﬁndings were reported
by Houang et al. [30].
Further studies need to be carried out to
determine whether point mutations are occurring
inside the gene [34] or if changes in the sequences
upstream of the cassette affect its expression [35].
Table 4. Comparison of the rates of resistance to antimicrobial agents among isolates of different epidemicity ribogroups
Antibiotics
Group I Group II Group III p-valuea
R5 (n = 131) R6 (n = 34) Others (n = 33) Group I vs. group II Group II vs. group III
PIP 130 34 30 0.794 0.114
PIP ⁄TAZ 128 33 22 0.606 0.003
AZT 128 34 32 0.498 0.492
CRO 131 34 30 ND 0.113
CAZ 130 32 30 0.108 0.485
FEP 120 23 23 <0.001 0.934
IMP 5 0 11 0.310 <0.001
AMP ⁄ SUL 119 25 7 0.011 <0.001
GEN 131 34 23 ND 0.004
AMK 125 34 28 0.244 0.025
TOB 130 34 22 0.794 <0.001
CHL 131 34 33 ND ND
CIP 130 33 8 0.371 <0.001
PIP, piperacillin; PIP ⁄TAZ, piperacillin with a ﬁxed concentration of tazobactam at 4 mg ⁄L; AZT, aztreonam; CRO, ceftriaxone; CAZ, ceftazidime; FEP, cefepime; IMP,
imipenem; AMP ⁄ SUL, ampicillin–sulbactam at a 2 : 1 ratio; GEN, gentamicin; AMK, amikacin; TOB, tobramycin; CHL, chloramphenicol; CIP, ciproﬂoxacin; ND, not
determined.
aA p-value <0.05 is considered to indicate a signiﬁcant difference in resistance between ribogroups.
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Although all of the intI1+ MDR-AB isolates
carried the chloramphenicol acetyltransferase cas-
sette gene (catB8), the resistance rate among the
intI1) MDR-AB isolates was higher, at 98.8%
(80 ⁄ 88).
Genes involved in chloramphenicol resistance
that are not encoded by integrons, e.g. the gene
encoding the intrinsic efﬂux pump adeABC [36],
may also be involved. Various proﬁles of antibiotic
resistance in the absence of integron-associated
genes suggest that other antibiotic resistancemech-
anisms may be involved in MDR-AB resistance
[37]. ESBL production screening yielded negative
results for all except one isolate, indicating that its
broad-spectrum b-lactam resistance may result
from other mechanisms [38]. However, this is the
ﬁrst time that an ESBL-producing, in this case VEB-
3-producing, isolate has been reported in Taiwan.
One intriguing ﬁnding is that the MBL gene
cassette carrying blaIMP-8 and those carrying
blaOXA-58 confer various susceptibilites to imipe-
nem (Table 3), demonstrating the involvement of
different carbapenem resistance mechanisms.
Furthermore, the concomitant presence of two
carbapenemases, VIM-11 and OXA-58, was iden-
tiﬁed in an imipenem-resistant MDR-AB strain
(Table 3); this had similarly been reported
previously in Greece [39]. In A. baumannii, plas-
mid-encoded OXA-58 was the most widespread
carbapenem-hydrolysing oxacillinase. The inser-
tion sequences associated with blaOXA-58 may
contribute a strong promoter as well as an
acquisition system for resistance [40]. The associ-
ation of blaOXA-58 with an insertion sequence
element or the presence of two carbapenemases
in these isolates are possibly the major causes of
high-level carbapenem resistance.
In this study, identical integron cassettes
appeared in clonally unrelated strains, whereas
clonally related strains appeared to carry different
integron cassettes (Table 2), supporting the notion
that the integron cassettes in MDR-AB are neither
genotype-speciﬁc nor genus-speciﬁc [41,42]. It is
generally considered that the acquisition of entire
integrons may be easier than that of individual
cassette genes [43,44].
An epidemic clone, R5, was identiﬁed as being
widespread in Taiwan (with a prevalence of
64.85%). In addition, an endemic clone (R6) was
found mostly in isolates from the northern hos-
pital. Both the epidemic and the endemic clones
were signiﬁcantly more resistant than the spo-
radic isolates (Table 4). The ribopattern of the R5
clone was identical to that of the previously
described R-25 clone, which was isolated in
another Taiwanese hospital [11]. With the excep-
tion of one strain, all R5 strains carrying the
type 3 cassettes have been reported to be associ-
ated with the worldwide MDR-AB outbreak clone
[8]. The circulation of R5 strains harbouring this
speciﬁc cassette arrangement may be associated
with unknown epidemicity properties. One spe-
ciﬁc feature of the R5 clone is its higher resistance
to various antibiotics than that of other integron-
carrying clones, suggesting that AmpC b-lactam-
ase [45] and penicillin-binding protein changes
[46] may be involved.
In conclusion, integrons appear to comprise
one of the common features among MDR-AB
isolates in Taiwan, and are associated with a high
prevalence of antibiotic resistance. An epidemic
integron-carrying MDR-AB clone of a speciﬁc
ribotype and carrying a speciﬁc cassette arrange-
ment (aacA4, catB8, aadA1) was identiﬁed and was
signiﬁcantly more resistant than other MDR-AB
clones.
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